STUDIES ON THE EXPRESSION AND IMMUNOGENICITY OF THE B50 MELANOMA ANTIGEN AND ITS RELATIONSHIP WITH CALRETICULIN

被引：4

作者：

BIJWAARD, K ^{[1
]}

HEARING, VJ ^{[1
]}

SONTHEIMER, R ^{[1
]}

LIEU, TS ^{[1
]}

VIEIRA, WD ^{[1
]}

GERSTEN, DM ^{[1
]}

机构：

[1] NCI,CELL BIOL LAB,BETHESDA,MD 20892

来源：

MELANOMA RESEARCH | 1995年 / 5卷 / 05期

关键词：

ANTIGEN; B50; MELANOMA; RO/SS-A COMPLEX;

D O I：

10.1097/00008390-199510000-00005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B50 is a 50 kDa protein antigen originally identified and isolated from cultured B16 murine melanoma cells; it is found in close association with a melanoma-specific antigen termed B700, Using a specific rabbit antiserum, B50 (or B50 cross-reactive molecules) has been shown to be expressed by 35 out of 35 cell lines, including melanomas, sarcomas, fibrosarcomas, carcinomas, gliomas, immortalized and primary fibroblasts, melanocyte and keratinocyte cell lines obtained from murine, human, hamster, swine, and canine donors, B50 expression is localized on the cellular membrane and in the cytoplasm in varying amounts in seven of the nine cell lines tested, Mice immunized to B50 demonstrated a significant tumour rejection response when subsequently challenged with B16 F10 melanoma cells. Previous studies had indicated that B50 has significant N-terminal amino acid sequence homology with calreticulin, Calreticulin, a calcium-binding protein, is part of the Ro/SS-A complex. This complex is the primary autoantigenic determinant of the autoimmune diseases systemic lupus erythematosus and primary Sjogren's syndrome, We now show that sera from patients with those diseases contain antibodies which bind B50, although B50 itself does not bind calcium, Thus, B50 and calreticulin are closely related but distinct antigens.

引用

页码：327 / 336

页数：10

共 47 条

[1]

Gersten D.M., Marchalonis J.J., Demonstration and isolation of murine melanoma-associated antigenic surface proteins, Biochem Biophys Res Comm, 90, pp. 1015-1024, (1979)

[2]

Gersten D.M., Williams L.J., Moody D., Et al., The intracellular association of B700 and B50 murine melanoma antigens and their role in tumor rejection, Int J Cancer, 43, pp. 497-500, (1989)

[3]

Gersten D.M., Hearing V.J., Antigens of murine melanoma and their cross-species reactivity, Pathobiology, 60, pp. 49-56, (1992)

[4]

Hearing V.J., Gersten D.M., Montague P.M., Et al., Murine melanoma-specific tumour rejection activity elicited by a purified, melanoma-associated antigen, J Immunol, 137, pp. 379-384, (1986)

[5]

Hearing V.J., Marchalonis J.J., Gersten D.M., Studies on the relationship of the B700 and B50 murine melanoma antigens, JNCI, 77, pp. 763-766, (1986)

[6]

Gersten D.M., Bijwaard K.E., Law L.W., Et al., Homology of the B50 murine melanoma antigen to the Ro/SS-A antigen of human systemic lupus erythematosus and to calcium-binding proteins, Biochim Biophys Acta, 1096, pp. 20-25, (1991)

[7]

Fidler I.J., The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis, Eur J Cancer, 9, pp. 223-227, (1973)

[8]

Bennett D.C., Cooper P.J., Hart I.R., A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumor promoter for growth, Int J Cancer, 39, pp. 414-418, (1987)

[9]

Bennett D.C., Cooper P.J., Dexter T.J., Et al., Cloned mouse melanocyte lines carrying the germline mutations albino and brown: Complementation in color, Development, 105, pp. 379-385, (1989)

[10]

Rheinwald J.G., Green H., Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells, Cell, 6, pp. 331-344, (1975)

← 1 2 3 4 5 →